ГОСТ ISO 10993-16-2016
a review, Food Chem. Toxicol.,43, pp. 203-216,2005
[13] DORNE.J.L., WALTON, K, SLOB, W. and RENWICK, A.G., Human variability in
polymorphic CYP2D6 metabolism, is the kinetic default uncertainty factor
adequate? Food Chem. Toxicol., 40, pp. 1633-1656, 2002
[14] DORNE, J.L., Human variability in hepatic and renal elimination: implications for
risk assessment. J. Appl. Toxicol.,27, pp. 411-420,2007
[15] DORNE, J.L., Impact of inter-individual differences in drug metabolism and
pharmacokinetics on safety evaluation, Fundam. Clin. Pharmacol., 18, pp. 609-
620,2004
[16] Drug discovery and evaluation: safety and pharmacokinetic assays. VOGEL,
H.G., et al. (eds), Springer Verlag, Berlin, 2006
[17] EKINS, S., et al., Present and future in vitro approaches for drug metabolism, J.
Pharmacol. Toxicol. Methods,44, pp. 313-324,2000
[18] ENGLISH, J.C., DEISINGER, P.J. and GUEST,D., Metabolism of 2-ethylhexanoic
acid administered orally or dermally to the female Fischer 344 rat, Xenobiotica, 28,
pp. 699-714, 1998
[19] FDA guideline for industry. Pharmacokinetics: Guidance for repeated dose tissue
distribution studies. Federal Register, 60 (40), pp. 11274-11275, 1995
[20] FORKERT, P.-G., Mechanisms of 1,1-dichloroethylene-induced cytotoxicity in
lung and liver. Drug Metab. Revs.,33, pp. 49-80,2001
[21] FRANTZ, S.W., et al., Pharmacokinetics of ethylene glycol II. Tissue distribution,
dose dependent elimination, and identification of urinary metabolites following
single intravenous, peroral or percutaneous doses in female Sprague-Dawley rats
and CD-1® mice,Xenobiotica,26, pp. 1195-1220,1996
[22] FUHR, U., Induction of Drug Metabolising Enzymes: Pharmacokinetic and
Toxicological Consequences in Humans, Clin. Pharmacokin., 38, pp. 493-504,
2000
[23] GOTT, D., Biodegradation and toxicokinetic studies, in BRAYBROOK, J.H. (ed).,
Biocompatibility assessment of medical devices and materials, John WILEY,
Chichester 1997
[24] GUNDERT-REMY, U. and SONICH-MULLIN,C., IPCS Uncertainty and Variability
Planning Workgroup and Drafting Group (International Program on Chemical
Safety). The use of toxicokinetic and toxicodynamic data in risk assessment: an
international perspective. Sci. Total Environ.,288, pp. 3-11,2002
16